Abstract P2-08-03: Survival analysis of the prospective randomized Cher-Lob study: Correlation with tumor infiltrating lymphocytes von Dieci, MV, Bisagni, G, Cagossi, K, Generali, DG, Sarti, S, Piacentini, F, Conte, P, Guarneri, V

Volltext

Abstract P4-21-11: T-DM1 in HER2 positive advanced breast cancer patients: Real world practice from a multicenter observational study von Fabi, A, De Laurentiis, M, Caruso, M, Valle, E, Moscetti, L, Santini, D, Cannita, K, Carbognin, L, Ciccarese, M, Rossello, R, Arpino, G, Leonardi, V, Montemurro, F, La Verde, N, Generali, DG, Zambelli, A, Scandurra, G, Russillo, M, Paris, I, D'Ottavio, AM, Filippelli, G, Giampaglia, M, Stani, S, Fabbri, A, Alesini, D, Giannarelli, D, Cognetti, F

Volltext

P4-16-03: Proof of the Anti-Tumour Effect of Zoledronic Acid (ZA) in Naive Bone-Only Metastatic and Locally Advanced Breast Cancer: Results from the Biological Window Therapy von Foroni, C, Andreis, D, Maldotti, M, Cappelletti, MR, Generali, DG

Volltext